###begin article-title 0
Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
In the vascular system, Notch receptors and ligands are expressed mainly on arteries, with Delta-like 4 (Dll4) being the only ligand known to be expressed early during the development of arterial endothelial cells and capillaries. Dll4 null embryos die very early in development with severely reduced arterial calibre and lumen and loss of arterial cell identity.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 142 146 142 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 207 211 207 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 491 495 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 495 499 495 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
The current detailed analysis of these mutants shows that the arterial defect precedes the initiation of blood flow and that the arterial Dll4-/- endothelial cells proliferate and migrate more actively. Dll4-/- mutants reveal a defective basement membrane around the forming aorta and increased endothelial cell migration from the dorsal aorta to peripheral regions, which constitute the main causes of arterial lumen reduction in these embryos. The increased proliferation and migration of Dll4-/- endothelial cells was found to coincide with increased expression of the receptors VEGFR-2 and Robo4 and with downregulation of the TGF-beta accessory receptor Endoglin.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Together, these results strongly suggest that Notch signalling can increase arterial stability and calibre by decreasing the response of arterial endothelial cells to local gradients of pro-angiogenic factors like VEGF.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 561 562 561 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
The initial steps of embryonic blood vessel formation (vasculogenesis) involve differentiation and aggregation of mesodermal-derived endothelial precursors (angioblasts) to generate the primary vascular plexus. Blood vessels then grow and remodel into a mature network of hierarchically organized vessels, in a process designated as angiogenesis. During this remodelling, endothelial vessels differentiate into arteries and veins, grow, sprout, split and fuse according to a combination of autocrine signalling and cues provided by other tissues of the embryo [1].
###end p 9
###begin p 10
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGF </italic>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR</italic>
###xml 404 408 404 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR-1</italic>
###xml 490 494 490 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 687 688 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 802 803 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 804 805 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1233 1234 1230 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1235 1237 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
The formation of the initial vascular plexus is highly dependent on vascular endothelial growth factor (VEGF-A) and its receptors, VEGFR-1 and VEGFR-2, since mouse embryos lacking these genes display very early vascular defects and die between 8.5-9.5 dpc [2-4]. Notably, VEGF haploinsufficiency causes embryonic lethality. VEGFR-2 is thought to be the major mediator of the VEGF signalling since VEGFR-2-/- embryos fail to form blood islands or organized blood vessels [3], whereas VEGFR-1-/- embryos form blood vessels with an excess of endothelial and haemangioblast progenitors [4,5]. Furthermore, deletion of the VEGFR-1 tyrosine kinase domain does not affect vascular development [6]. In some contexts VEGFR-1 seems to work as a biological sink to VEGF, antagonizing VEGFR-2 mediated signalling [7,8]. Through activation of VEGFR-2, VEGF induces phosphorylation of several proteins which in turn regulate endothelial cell permeability, proliferation, migration and survival. During later vessel remodelling, other ligands become increasingly important and the disruption of the signalling induced by angiopoietins, ephrins, TGF-beta, slits or netrins causes specific vascular defects that often leads to early embryonic death [9,10].
###end p 10
###begin p 11
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 150 157 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch4 </italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 494 505 494 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGF, Dll4 </italic>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 711 715 711 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 786 790 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 790 794 790 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 867 871 867 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 871 875 871 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 951 957 951 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Efnb2 </italic>
###xml 961 966 961 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gja4 </italic>
###xml 967 971 967 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cx37</italic>
###xml 1014 1019 1014 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ephb4</italic>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
The Notch pathway is also involved in the regulation of vascular development as the single gene deletion of Notch1 or combined deletion of Notch1 and Notch4 results in severe defects in early arterial development [11]. The Notch receptors can bind five known ligands from the Delta (Dll1, Dll3 and Dll4) and Jagged (Jagged1 and Jagged2) families. The Dll4 ligand is the only canonical Notch ligand strongly expressed in arterial endothelial cells at early stages of development [11,12]. Beside VEGF, Dll4 is the only other known vascular-related haploinsufficient lethal gene, indicating how critical its dosage levels are for vascular development [13-15]. We have previously shown that the majority of the Dll4+/- embryos die at 10.5 dpc in the CD1 genetic background, whereas all the Dll4-/- embryos die at 9.5 dpc with severely reduced dorsal aortae. Furthermore, Dll4-/- aortic endothelial cells lose the expression of the arterial-specific genes Efnb2 and Gja4 (Cx37), and ectopically express the vein marker Ephb4, one of the receptors for the arterial ephrinB2 ligand [15].
###end p 11
###begin p 12
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 140 144 140 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
In order to understand the cause of this arterial calibre and lumen reduction, a stepwise analysis of the early vascular development of Dll4-/- embryos was carried out.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 14
###begin p 15
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 431 435 431 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
All procedures complied with the standards for care and use of animal subjects as stated in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences of the U.S.A.) and were approved by the institutional committee for the ethical use of laboratory animals of the Faculdade Medicina Veterinaria (project POCTI 48677). Embryos were obtained by the intercross of Dll4+/- mice in the CD1 genetic background as described previously [15]. These heterozygous mice were kept in the CD1 genetic background due to the higher lethal haploinsufficiency in the other tested genetic backgrounds (almost 100%). The embryonic age was initially determined by the date of the formation of the copulation plug and confirmed by the number of somites.
###end p 15
###begin title 16
X-Gal staining, immunofluorescence and in situ hybridization
###end title 16
###begin p 17
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
Whole-mount immunohistochemistry and X-gal staining were carried out by standard techniques [16]. For sections, after fixation in 4% paraformaldehyde (PFA), embryos were cryoprotected in 15% sucrose, embedded in 7.5% gelatine and cryosectioned at 12 mum. Antibodies against PECAM-1 (Pharmingen), alpha SMA (Sigma), SM22alpha (Abcam), beta-catenin (Sigma), Fibronectin (Sigma), Endoglin (Pharmingen), Laminin (Abcam) and CollagenIV (Chemicon) were used as primary antibodies and species-specific conjugated to Alexa Fluor (Molecular Probes) were used as secondary antibodies.
###end p 17
###begin p 18
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Flk1 </italic>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Flt1 </italic>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey1 </italic>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFA </italic>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 472 480 472 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 561 568 561 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 615 620 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 748 755 748 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 786 791 786 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 819 824 819 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">situ </italic>
In situ hybridization of cryostat sections with digoxigenin labelled riboprobes Dll4 (full-length); Flk1 [17]; Flt1 [4]; Notch1 (a 2168 bp BamHI-EcoRV fragment of the NM_008714 cDNA clone, starting at nucleotide 4205 and ending at nucleotide 6373); Hey1 [18], VEGFA [19], was essentially done as previously described [20]. After overnight incubation with anti-Dig-AP (1:2000, Roche) the signal was developed with Fast Red solution (Roche) or BM purple (Roche). The double in situ hybridization was done with the Dll4 riboprobe labelled with fluorescein and the Notch1 with digoxigenin. For the amplification of the Dll4 signal was used the anti-Fluo-POD (1:100, Roche) and the FITC-tyramide from the TSA-Plus Fluorescein System (Perkin Elmer). The Notch1 signal was developed after the Dll4 signal as for the single in situ hybridizations. Fluorescence images were acquired on a Leica DM5000B microscope (sections) or an Olympus SZX12 stereomicroscope (wholemount). Confocal images were acquired using a Leica Spectral AOBS microscope. All the images were processed on Adobe Photoshop 9.0.
###end p 18
###begin title 19
BrdU and TUNEL labelling
###end title 19
###begin p 20
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
BrdU labelling was achieved by a 2 hour BrdU pulse (100 ug BrdU/g body weight, intraperitoneally) before fixation in 4% PFA. Cryosections from the fixed embryos were treated in 50% formamide/1 x SSC, pH = 7 for 1 hour at 65degreesC and HCl (7.5%) for 30 minutes at 37degreesC and incubated overnight with mouse anti-BRDU (1:1000, Sigma). To visualize the nucleus a15 minute incubation in DAPI solution followed by a brief fixation in 4% PFA was performed before the DNA denaturation. Endothelial anti-PECAM-1 immunostaining was performed also before the BrdU immunostaining. In this experiment we used consecutive cryosections from all the anterior-middle region of the embryos (2 embryos from each genotype). From each cryosection a 3 channel picture was taken and used to score the number of total and proliferating aortic endothelial cells.
###end p 20
###begin p 21
###xml 142 150 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
To detect apoptotic endothelial cells on cryosections, anti-PECAM-1 and DAPI staining after TUNEL labelling and staining with the fluorescein in situ cell death detection it (Roche) was performed. Cell counting was carried out as described for the BrdU staining.
###end p 21
###begin title 22
Quantitative PCR
###end title 22
###begin p 23
###xml 526 536 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin</italic>
###xml 576 587 573 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 644 651 638 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR2 </italic>
###xml 709 716 703 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR1 </italic>
###xml 775 781 769 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFA </italic>
###xml 840 845 834 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey1 </italic>
###xml 903 906 897 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey</italic>
###xml 968 973 962 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cx37 </italic>
###xml 1031 1040 1025 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Endoglin </italic>
###xml 1099 1105 1093 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo4 </italic>
###xml 1167 1173 1161 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PECAM </italic>
Total RNA was extracted from whole embryos, after removal of the yolk sac, with the RNeasy Mini Kit (Qiagen). cDNA synthesis was done using the Superscript III First Strand Synthesis kit (Invitrogen). In two different experiments embryos were obtained from two different litters (n = 4 for each genotype). In each experiment, for each analysed gene, 6 separate real time PCR (RT-PCR) reactions were carried out, in triplicates, using SYBR Green Mixes and ABI PRISM 7300 (Applied Biosystems). Gene expression was normalised to beta-actin. Used Primer sequences are as follows: beta-actin 5'-TGTTACCAACTGGGACGACA-3'and 5'-GGGGTGTTGAAGGTCTCAAA-3';VEGFR2 5'-GGCGGTGGTGACAGTATCTT-3' and 5'-GAGGCGATGAATGGTGATCT-3' VEGFR1 5'-GACCCTCTTTTGGCTCCTTC-3'and 5'-CAGTCTCTCCCGTGCAAACT-3' ; VEGFA 5'-GGAGAGCAGAAGTCCCATGA-3' and 5'-ACACAGGACGGCTTGAAGAT-3'; Hey1 5-CACCTGAAAATGCTGCACAC-3' and 5'-ATGCTCAGATAACGGGCAAC-3'; Hey2 5'-TGCCAAGTTAGAAAAGGCTGA-3' and 5'-CACTCTCGGAATCCAATGCT-3'; Cx37 5'-ACGGTCGTCCCCTCTACCT-3' and 5'-GTCGAGTGTTCCTGGACCTG-3'; Endoglin 5'-CACACCTCCCAAGGACACAT-3' and 5'-TGGAGTCCCAGAAAGTCAGG-3'; Robo4 5'-CGAGGACGCCATTCTAAAAC-3' and 5'-CCAATCCCAGCCGACTACTA-3' and PECAM 5'-GTGGTCATCGCCACCTTAAT-3' and 5'-GGCTTCCACACTAGGCTCAG-3'.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 32 36 32 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Reduced arterial calibre in Dll4-/- embryos is determined before the onset of blood flow and is not caused by defects in angioblast differentiation
###end title 25
###begin p 26
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 326 330 326 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 544 548 544 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 707 712 707 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A, B</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
The Dll4 gene starts to be expressed in the embryo at the 2-somite stage in the endothelium of the developing heart and dorsal aortae [15]. As the development of the dorsal aortae is coincident with heart development and the initiation of blood flow, we asked if the early arterial calibre and lumen reduction seen in the Dll4-/- embryos could be related to impaired haemodynamic forces, which are known to influence arterial identity and remodelling [21]. Confocal imaging of the dorsal aortae of 8-somite stage (ss) embryos shows that in Dll4-/- embryos the arterial calibre and lumen is already significantly reduced before the initiation of heart beat and blood flow, which begins around 10-11 ss (Fig. 1A, B). Together with previous observations [22], these results suggest that the initial regulation of blood vessel size is an intrinsic property of early endothelial cells.
###end p 26
###begin p 27
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 57 61 57 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The dorsal aortae calibre and lumen reduction in the <italic>Dll4</italic><sup>-/- </sup>embryos is not caused by blood flow or angioblast defects</bold>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, B</italic>
###xml 121 125 121 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A, B</italic></bold>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 165 169 165 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 177 181 177 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 368 371 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-F</italic>
###xml 368 371 365 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>C-F</italic></bold>
###xml 401 409 398 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 458 462 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 462 466 459 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 558 559 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 655 660 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 730 738 <span type="species:ncbi:405018">cardinal</span>
The dorsal aortae calibre and lumen reduction in the Dll4-/- embryos is not caused by blood flow or angioblast defects. (A, B) Confocal imaging analysis of 8 ss Dll4+/+ and Dll4-/- embryos showing in red the dorsal aortae (da) endothelial cells (labelled with anti-PECAM-1) and in blue all the other cells from the adjacent tissues (labelled with anti-beta-catenin). (C-F) Anti-PECAM-1 or fluorescent in situ hybridization on consecutive cryosections from a Dll4+/+ 8 ss embryo, showing that VEGFR-2 and Notch1 are expressed in the endothelial cells (PECAM-1+) and in the mesoderm cells from the lateral plate (green arrows), where angioblasts arise. The Dll4 mRNA is not detected on the angioblasts or on the primordial anterior cardinal vein (white arrowheads) but only on aortic endothelial cells (white arrows). (Scale Bars: 15 mum).
###end p 27
###begin p 28
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 370 378 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 412 419 412 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 542 543 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 563 571 563 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C, D, E</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 719 723 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 723 727 723 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 831 836 831 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
The reduction of the arterial calibre could arise from either defects in the maturation of the dorsal aorta once formed or from abnormal differentiation and impaired migration of angioblasts from the lateral plate mesoderm to the midline of the embryo. Angioblasts are endothelial progenitors and express high levels of VEGFR-2 and no detectable levels of PECAM-1 [22]. In situ hybridization with probes for the Notch1 and Dll4 mRNAs shows that Dll4 is not expressed in cells from the lateral plate mesoderm, where angioblasts (VEGFR-2+/PECAM-) are located (Fig. 1C, D, E and 1F), and only becomes expressed after initiation of aorta formation. This indicates that the reduction of the arterial calibre observed in the Dll4-/- embryos is not caused by defects in early angioblast differentiation or migration to the midline, since Dll4 is only expressed at the aortic endothelium at this stage.
###end p 28
###begin title 29
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Dll4-/- arterial endothelial cells display abnormal morphology and a defective basement membrane
###end title 29
###begin p 30
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 27 31 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 371 375 371 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 527 532 527 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 905 909 905 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G-T</xref>
###xml 1030 1034 1030 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1034 1038 1034 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1477 1481 1477 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1481 1485 1481 1485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
To study the nature of Dll4-/- endothelial cell phnotype we analysed endothelial morphology and extracellular matrix integrity in embryos with 8-11 somites, the stage immediately before the onset of circulation and when the phenotype starts to become more pronounced. The analysis of transverse sections labelled with the endothelial marker PECAM-1 revealed that the Dll4-/- aortic endothelial cells, in the anterior and middle region of the embryo, are frequently more aggregated and do not acquire a spindle-like shape (Fig. 2A, B and 2C). The majority of these cells display a rounder morphology which is characteristic of incompletely differentiated or loosely attached endothelial cells. Interestingly, fibronectin, laminin and collagenIV immunostaining further revealed that these cells have a severely defective basement membrane in both the anterior and posterior (presomitic) dorsal aortae (Fig. 2G-T). Whereas in a normal developing dorsal aorta there is accumulation of a thick layer of surrounding fibronectin, in the Dll4-/- embryos the endothelial matrix is very irregular and some of the arterial endothelial cells are not in direct contact with it. These defects occur both in the anterior and presomitic domains of the dorsal aortae, whereas the arterial calibre reduction occurs only in the anterior domain. This suggests that the defects observed in basement membrane integrity are not sufficient to explain the reduction in the arterial calibre seen in the Dll4-/- embryos.
###end p 30
###begin p 31
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 132 0 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The <italic>Dll4</italic><sup>-/- </sup>arterial endothelial cells have an abnormal morphology, become more aggregated and display a defective basement membrane</bold>
###xml 135 138 135 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 220 224 220 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 232 236 232 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 328 332 328 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 332 336 332 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 450 451 450 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 477 478 477 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 482 483 482 483 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 565 569 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 569 573 565 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 751 755 743 747 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E, F</bold>
###xml 921 924 909 912 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-R</bold>
###xml 1031 1034 1019 1022 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-L</bold>
###xml 1051 1054 1039 1042 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M-R</bold>
###xml 1072 1076 1060 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1076 1080 1064 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1084 1088 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1088 1092 1076 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1109 1113 1097 1101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I-L </bold>
###xml 1117 1121 1105 1109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">O-R </bold>
###xml 1266 1270 1254 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1270 1274 1258 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1416 1420 1404 1408 <bold xmlns:xlink="http://www.w3.org/1999/xlink">S, T</bold>
###xml 1609 1613 1597 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1613 1617 1601 1605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
The Dll4-/- arterial endothelial cells have an abnormal morphology, become more aggregated and display a defective basement membrane. (A-C) Anti-PECAM-1 staining of 8 ss embryo cryosections showing the morphology of Dll4+/+ and Dll4-/- dorsal aortae endothelial cells. The white stars label the DAPI stained endothelial nuclei. Dll4-/- endothelial cells are more aggregated and fail to develop a stretched spindle-like form which leads to a reduced (B) or absent aortic lumen (C). (D) Anti-PECAM-1 (red) and anti-alphaSMA (green) staining of 16 ss cryosection of a Dll4+/+ embryo showing the absence of arterial (a) and venous (v) endothelium associated smooth muscle cells. Note the strong alphaSMA staining in the endoderm (e) and pericardium (p). (E, F) Both control and mutant dorsal aortae (a) are surrounded by neural crest derived smooth muscle cell progenitors with high amounts of Sm22alpha protein (in green). (G-R) Anti-PECAM-1 (red), anti-fibronectin (green) and DAPI (blue) staining of cryosections from the anterior (G-L) and posterior (M-R) region of 11 ss Dll4+/+ and Dll4-/- embryos. Figures I-L and O-R are close ups of the upper left dorsal aortae and show the defective basement membrane (green) in both the anterior and posterior regions of the Dll4-/- aortae. In the mutants many endothelial cells are not in direct contact with the underlying, fibronectin-rich, extracelular matrix (arrows). (S, T) At this stage of development the aortic (a) basement membrane is relatively poor in laminin (S, control) and collagenIV (T, control) when compared with fibronectin (J and P). The reduced Dll4-/- dorsal aortae have even less and more irregular laminin and collagenIV coverage. (Scale Bars: 30 mum).
###end p 31
###begin title 32
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Dll4-/- aortic defects precede smooth muscle development
###end title 32
###begin p 33
###xml 257 259 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 265 273 261 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 291 298 287 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdgfrb </italic>
###xml 318 322 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 322 326 318 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 564 569 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 947 952 931 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E, F</xref>
###xml 1151 1155 1127 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1155 1159 1131 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1337 1341 1309 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1341 1345 1313 1317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1570 1575 1538 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
Besides the formation of the basement membrane, another biological process that confers stability and cohesion to the developing arteries is the recruitment of pericytes and smooth muscle cells. Immunostaining for alpha smooth muscle actin (alphaSMA) (Fig. 2D) and in situ hybridization for Pdgfrb (data not shown) on Dll4+/+ embryonic sections at this developmental stage, showed that there is virtually no differentiated smooth muscle cells or pericytes associated with the endothelium of these primordial arteries. To further investigate a possible function of Dll4 in arterial smooth muscle cell recruitment we did imunostaining for Sm22alpha a gene highly expressed by neural crest derived smooth muscle cells and progenitors. We detected Sm22alpha in several cells surrounding the control and mutant aortic endothelium but just some Sm22alpha positive cells were found immediately adjacent and adherent to the aortic endothelial cells (Fig. 2E, F). Most of the mural cells Sm22alpha+ in contact with the endothelial cells showed a round shape and were not completely attached to it. In fact we detected less Sm22alpha+ cells in contact with the Dll4-/- aortas, although this can be related to the reduced arterial calibre and available endothelial cell surface. We also analysed Sm22alpha staining in the pre-somitic region, where Dll4-/- and control aortae have a similar calibre, but at this level we could not observe Sm22alpha+ cells surrounding the aorta of either control or mutant embryos. These results suggest that the arterial phenotypic consequences of Dll4 loss of function precede the existence of fully differentiated supporting cells in the arteries.
###end p 33
###begin title 34
Loss of the Notch ligand Dll4 increases endothelial cell proliferation and migration
###end title 34
###begin p 35
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 32 36 32 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 258 262 258 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 270 274 270 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 452 456 452 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 456 460 456 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 658 662 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 662 666 662 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 716 721 716 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B, D</xref>
###xml 846 850 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 850 854 850 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
To further characterize the Dll4-/- endothelial cell behaviour we analysed the in vivo proliferation and migration of endothelial cells. To detect the primary defect the analysis of the aortic endothelial cell number and proliferation rate was done with Dll4+/+ and Dll4-/- embryos with 8 somites. Each embryo was serially sectioned and immunostained for PECAM-1 and BrdU. At this early stage of development there are 28% less endothelial cells in the Dll4-/- aortae compared to the control dorsal aortae (Fig. 3A), and as development proceeds this difference becomes more pronounced (data not shown). Unexpectedly, however, the proliferation rate of aortic Dll4-/- endothelial cells is almost two-fold higher (Fig. 3B, D). This apparent contradiction could be explained by either increased apoptosis or increased outward migration of the aortic Dll4-/- endothelial cells. To test the first hypothesis, we performed TUNEL analysis, which showed that although there is an increase of endothelial cell apoptosis, its rate is too low to counterbalance the increase in endothelial cell proliferation (Fig. 3C).
###end p 35
###begin p 36
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 56 60 56 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased proliferation, sprouting and migration of <italic>Dll4</italic><sup>-/- </sup>arterial endothelial cells</bold>
###xml 88 93 88 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-C)</bold>
###xml 293 294 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 294 297 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ll4</italic>
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 358 361 358 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D)</bold>
###xml 609 614 609 614 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E-J)</bold>
###xml 752 756 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 756 760 756 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 857 861 857 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 861 865 861 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1120 1124 1120 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1124 1128 1124 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1258 1262 1258 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1262 1266 1262 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1341 1345 1341 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1345 1349 1345 1349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1414 1420 1414 1420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(K, L)</bold>
###xml 1497 1501 1497 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1501 1505 1501 1505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1577 1583 1577 1583 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(M, N)</bold>
###xml 1610 1614 1610 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGF</italic>
###xml 1870 1876 1870 1876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s.e.m.</italic>
Increased proliferation, sprouting and migration of Dll4-/- arterial endothelial cells. (A-C) Quantification of the endothelial cell number per aortic section (A), percentage of proliferating endothelial cells (B), and percentage of apoptotic endothelial cells (C) in the aortae of 8ss Wt and Dll4-/- embryos (n=2 for each genotype, 30 sections per embryo). (D) Representative images of the sections used for quantification. Endothelial cells are shown in red (anti-PECAM-1), nuclei in blue (DAPI) and proliferating cells in green (anti-BRDU). The proliferating endothelial cells are also indicated (arrows). (E-J) Whole-mount embryos labelled with anti-PECAM-1 (E-H, green) or X-gal (I, J) showing the increased migration of intersomitic vessel (isv) Dll4-/- endothelial cells. (E, F) Confocal imaging of the somitic region of 10ss embryos showing that in Dll4-/- embryos (F) the aortae endothelial cells invade the intersomitic space earlier and migrate extensively, causing the calibre reduction of the dorsal aortae (da). (G, H) At 12ss the endothelial cells start to accumulate in the dorsal domain (arrows) of the Dll4-/- embryos. (I, J) The X-gal staining of 14ss embryos shows the accumulation of endothelial cells (blue) in the dorsal region of the Dll4-/- first anterior-middle somites (J), forming a large dorsal vessel (dv). The Dll4-/- cells also migrate extensively to the primordial limb buds (lb). (K, L) Confocal imaging of 14ss wholemount embryos labelled with anti-PECAM-1. The Dll4-/- dorsal aortae (da) are thinner and show extensive sprouting (red dots). (M, N) In situ hybridization for VEGF mRNA on cryosections of a 12ss embryo shows that in the anterior region (M), VEGF is expressed by both the neural tube (nt) and endoderm (e) cells, but in the posterior (pre-somitic) region (N) is only expressed by the endoderm cells. Error bars indicate s.e.m. (Scale Bars: D, 25mm; E-J, 150mm; K-N, 100mum).
###end p 36
###begin p 37
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 104 108 104 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E&#8211;J</xref>
###xml 516 520 516 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 520 524 520 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3J</xref>
###xml 930 938 930 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 972 979 972 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGF-A </italic>
###xml 1113 1119 1113 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGF-A</italic>
###xml 1188 1195 1188 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGF-A </italic>
###xml 1268 1273 1268 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3M, N</xref>
###xml 1555 1559 1555 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1559 1563 1559 1563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
The sequential analysis of the intersomitic vessel development from 10 to 14 ss embryos showed that Dll4-/- aortic endothelial cells migrate earlier and faster through the intersomitic space and accumulate in excessive numbers in the region of dorsal anastomotic vessel formation (Fig. 3E-J). Every time a somite forms in the posterior region a new gradient of angiogenic factors is established within the newly formed intersomitic space boundaries, which attracts the endothelial cells. Therefore, the migration of Dll4-/- endothelial cells is more advanced in the first than in the last somites. Consequently, the mutant dorsal aortae calibre is also much more reduced in the anterior somites and increases gradually until the most posterior somites and presomitic mesoderm, where its calibre is normal (Fig. 3J). To further investigate how these embryonic tissues regulate this gradual endothelial cell migration, we performed in situ hybridization with a probe to the VEGF-A mRNA on embryonic sections. In the anterior and middle regions of the embryo, the neural tube and the endoderm express high levels of VEGF-A, but in the presomitic mesoderm, where dorsal aortae do not sprout, VEGF-A mRNA was only detected in the endoderm, close to the dorsal aortae (Fig. 3M, N). This indicates that the neural tube, and not only the somites, can be a regulator of intersomitic vessel sprouting and dorsal growth. The results suggest that in the absence of angiogenic gradients secreted by the somites and the neural tube (as in the presomitic mesoderm), the Dll4-/- endothelial cells remain associated with the dorsal aortae and form a normal arterial lumen, even though they have a defective basement membrane as described above.
###end p 37
###begin p 38
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 149 151 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 187 192 187 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3I, J</xref>
###xml 576 581 576 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3K, L</xref>
###xml 681 685 681 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 685 689 685 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 845 850 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 351 359 <span type="species:ncbi:405018">cardinal</span>
This increased migration of arterial endothelial cells also occurs towards the region of the developing limb bud, where an accumulation of Dll4-lacZ + endothelial cells can be seen (Fig. 3I, J). In the anterior asomitic region of the embryo there is also an increased accumulation of endothelial cells in a dorsal region where the primordial anterior cardinal vein arises and develops. Confocal analysis shows increased but restricted sprouting of endothelial cells from the dorsal aortae, since we did not observe further extension and somite invasion of these sprouts (Fig. 3K, L). Altogether, these results suggest that the dorsal aortae calibre and lumen reduction seen in the Dll4-/- embryos is mainly caused by the increased outward migration of the endothelial cells from the central dorsal aortae to peripheral regions of the embryo. As Dll4 is not expressed in non-vascular tissues at these stages of development, the observed phenotype suggests a specific increase of endothelial cell response to normal angiogenic attractant gradients produced by surrounding tissues.
###end p 38
###begin title 39
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 31 35 31 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Venous localization of the Dll4-/- "arterial" endothelial cells
###end title 39
###begin p 40
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 434 438 434 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 632 636 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 636 640 633 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 798 802 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A&#8211;D</xref>
###xml 880 885 877 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G, H</xref>
###xml 1140 1145 1137 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E, F</xref>
###xml 1206 1210 1203 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1210 1214 1207 1211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1560 1564 1557 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1564 1568 1561 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1621 1627 1618 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ephb4 </italic>
###xml 1688 1693 1685 1690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Efnb2</italic>
###xml 156 164 <span type="species:ncbi:405018">cardinal</span>
###xml 743 751 <span type="species:ncbi:405018">cardinal</span>
One of the distinguishable features of mammalian arterial and venous early development is that the venous angioblasts migrate and form the initial anterior cardinal vein in a dorsal position close to the neural tube, whereas arterial angioblasts form the dorsal aortae ventrally and close to the endoderm. Little is known about the molecular mechanisms that regulate this early segregation of arterial and venous lineages. In the Dll4-/- embryos we can follow the migration of arterial endothelial cells by analysis of lacZ expression, because the beta-galactosidase protein is very stable. In the anterior, asomitic region, of the Dll4-/- embryos abnormal migration of "arterial" endothelial cells to the region where the primordial anterior cardinal veins form was very frequently observed (Fig. 4A-D). This migration is frequently associated with arterial-venous fusions (Fig. 4G, H) and an increase of the pool of venous endothelial cells. At later stages, in the middle (somitic) region of the embryo, almost all arterial endothelial cells localize dorso-laterally to the neural tube and not ventrally as in the wild-type embryo (Fig. 4E, F). The observed migration and delocalization of the arterial Dll4-/- endothelial cells to the dorsal and venous region can be related with the incomplete differentiation of the "arterial" endothelial cells and abnormal increased responsiveness to the angiogenic factors produced by the neural tube. Alternatively, these cells can be less sensitive to the existing repulsive factors. We previously showed that these Dll4-/- "arterial" endothelial cells express the vein marker Ephb4 and fail to express detectable levels of the arterial marker Efnb2. So these uncommitted "arterial" endothelial cells may respond to the distribution of the gradients like the venous angioblasts or endothelial cells.
###end p 40
###begin p 41
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 114 0 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Dll4</italic><sup>-/- </sup>endothelial cells migrate dorsally towards the neural tube, fusing with developing anterior cardinal veins</bold>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 237 241 237 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 249 253 249 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 297 300 297 300 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-D</bold>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 306 310 306 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 606 610 603 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E, F</bold>
###xml 878 882 875 879 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G, H</bold>
###xml 926 930 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 930 934 927 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 100 108 <span type="species:ncbi:405018">cardinal</span>
###xml 549 557 <span type="species:ncbi:405018">cardinal</span>
###xml 1026 1034 <span type="species:ncbi:405018">cardinal</span>
Dll4-/- endothelial cells migrate dorsally towards the neural tube, fusing with developing anterior cardinal veins. X-gal (A-F) and anti-PECAM-1 (G, H) staining of cryosections from the anterior (A, B) and middle (C-F) region of the Dll4+/- and Dll4-/- embryos with 8.5 (A-D) and 9.25 dpc (E-H). (A-D) Dll4-/- arterial endothelial cells migrate (arrows in B and D) towards the dorso-lateral region of the neural tube. In the anterior region of the Dll4 null embryos, the aortic (a, beta-galactosidase+) cells migrate towards the developing anterior cardinal vein (v), before the onset of circulation (B). (E, F) At later stages, in the middle region of the embryo, this dorsal migration leads to the delocalization of the dorsal aortae. The main circulation in the mutant embryos occurs through two vessels that localize laterally (F) and not ventrally (E) to the neural tube. (G, H) In the anterior region of the later-stage Dll4-/- embryos the fusion (arrows) between the dorsal sprouting of the aortae (a) and the anterior cardinal veins (v) is evident. (Scale Bars: 50 mum).
###end p 41
###begin title 42
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 13 17 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Arterial Dll4-/- endothelial cells express more VEGFR-2 and Robo4 and less Endoglin
###end title 42
###begin p 43
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 110 114 110 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 665 673 665 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR-2 </italic>
###xml 697 701 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 701 705 701 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 745 750 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR</italic>
###xml 778 784 778 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo4 </italic>
###xml 811 820 811 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Endoglin </italic>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 859 864 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 922 929 922 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR-2</italic>
###xml 931 937 931 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo4 </italic>
###xml 941 950 941 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Endoglin </italic>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1135 1140 1135 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PECAM</italic>
###xml 1229 1233 1229 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cx37</italic>
###xml 1370 1374 1370 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1374 1378 1374 1378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1430 1433 1430 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey</italic>
###xml 1439 1442 1439 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey</italic>
###xml 1624 1632 1624 1632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1649 1653 1649 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1653 1657 1653 1657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1684 1689 1684 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey1 </italic>
###xml 1734 1736 1734 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6I</xref>
###xml 1786 1789 1786 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie</italic>
###xml 1796 1808 1796 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VE-cadherin </italic>
###xml 1870 1874 1870 1874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1874 1878 1874 1878 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
To better understand the molecular mechanisms that can be at the origin of this abnormal behaviour of the Dll4-/- endothelial cells we performed quantitative RT-PCR for several known early angiogenesis regulator genes. The analysis was done with total RNA extracted from 11 ss embryos. This stage was selected because the effects of the mutation and defective blood flow in remodelling are just starting and the expression of known arterial markers is increased comparative to earlier stages. The use of total RNA from the embryos limited our ability to determine the expression changes specifically within endothelial cells. The results show a 41% increase in the VEGFR-2 expression level in the Dll4-/- embryos and no significant variation of VEGFR-1 expression. In addition, Robo4 was upregulated by 56% and Endoglin downregulated by 41% (Fig. 5A). As the Dll4 gene is only expressed in the embryonic arteries, whereas VEGFR-2, Robo4 and Endoglin are also expressed in angioblasts and venous endothelial cells [17,23-25], this difference could be even more significant if RNA from only arterial endothelial cells had been used. The PECAM-1 expression level was used as a control of the endothelial fraction in the samples and Cx37, a known arterial specific marker, was used as a control of arterial differentiation. Its expression is reduced almost four-fold in the Dll4-/- embryos. As expected, the canonical Notch effectors Hey1 and Hey2 are also downregulated in the mutants. The reduction in the expression level is probably not higher because these two genes are also expressed in other non-endothelial tissues. By in situ hybridization on Dll4-/- sections we did not detect Hey1 mRNA in the arterial endothelial cells (Fig. 6I). On the other hand, the levels of expression of Tie-2 and VE-cadherin genes showed no significant differences between wild-type and Dll4-/- embryos (data not shown).
###end p 43
###begin p 44
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR-2 </italic>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo-4 </italic>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 80 84 80 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Higher expression of <italic>VEGFR-2 </italic>and <italic>Robo-4 </italic>but lower expression of Endoglin in <italic>Dll4</italic><sup>-/- </sup>embryos</bold>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 142 146 142 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 170 174 170 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 284 288 284 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 345 348 342 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B-D</bold>
###xml 350 358 347 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 449 453 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 453 457 450 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 513 517 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 517 521 513 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 669 673 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 673 677 669 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 785 786 781 782 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 819 823 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 942 946 938 942 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E, F</bold>
###xml 948 970 944 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR1 (Flt1) in situ </italic>
###xml 1121 1125 1117 1121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G, H</bold>
###xml 925 933 <span type="species:ncbi:405018">cardinal</span>
Higher expression of VEGFR-2 and Robo-4 but lower expression of Endoglin in Dll4-/- embryos. (A) Relative quantitative gene expression in Dll4-/- embryos compared to Dll4+/+ (n = 4 per group) show increased expression of VEGFR-2 and Robo-4 and lower expression of Endoglin in the Dll4-/- mutants. Values were normalized to those of beta-actin. (B-D) In situ hybridization on 9.0 dpc embryos cryosections show upregulation of VEGFR-2 specifically in Dll4-/- dorsal aortae (a). (B) In a thick section (50 mum) of a Dll4+/- embryo strong expression of Dll4 can be observed on the dorsal aortae and intersomitic vessels but no expression is detected on veins (v). (C) In a Dll4+/+ embryo VEGFR-2 is highly expressed in the veins and weakly expressed on the Dll4 expressing dorsal aortae. (D) In the absence of the arterial Dll4, VEGFR-2 is expressed at the same or at a higher level in the dorsal aortae compared to the anterior cardinal veins. (E, F) VEGFR1 (Flt1) in situ hybridization (in red) showing similar endothelial expression levels between control and mutant aortae (a) and umbilical arteries (ua). DAPI in blue. (G, H) Imunostaining for Endoglin (CD105) showing similar protein levels in endothelial cells of control and mutant embryos. Error bars represent st.dev. * indicates p < 0.05. (Scale Bars: 100 mum).
###end p 44
###begin p 45
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 0 131 0 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 and <italic>Dll4 </italic>are expressed at different levels in different cells but at high levels in the same cell of the developing arteries</bold>
###xml 134 137 134 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 213 217 213 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey1 </italic>
###xml 321 324 321 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D-F</bold>
###xml 333 341 333 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 359 366 359 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 463 470 463 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 565 568 565 568 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-I</bold>
###xml 577 581 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 581 585 581 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 506 514 <span type="species:ncbi:405018">cardinal</span>
Notch1 and Dll4 are expressed at different levels in different cells but at high levels in the same cell of the developing arteries. (A-C) In situ hybridization on consecutive cryosections of 8.75 dpc (12 ss) Dll4+/+ embryos showing that Notch1, Dll4 and Hey1 are expressed (red) in almost all aortic endothelial cells. (D-F) Double in situ hybridization for Notch1 and Dll4 reveals that these genes are expressed at high levels in the same cells. Note also that Notch1 is weakly expressed on the anterior cardinal veins (v), where there is no expression of Dll4. (G-I) In the Dll4-/- embryos the Notch1 receptor is still expressed on dorsal aortae (da) but there is no detectable endothelial expression of the effector Hey1 (I), although its expression remains in the pericardium (p). (Scale Bars: 50 mum).
###end p 45
###begin p 46
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR</italic>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 162 166 162 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR</italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 400 405 400 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B, C</xref>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 434 438 434 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR</italic>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 568 576 568 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR</italic>
###xml 699 703 699 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 703 707 703 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 711 715 711 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 715 719 715 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 806 810 806 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 810 814 810 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 845 850 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VEGFR</italic>
###xml 857 862 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo4</italic>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1046 1055 1043 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1097 1099 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1105 1113 1102 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1178 1180 1175 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
Since these qRT-PCR results represent differences in whole embryo expression levels, in situ hybridization with a probe for the VEGFR-2 mRNA on wild-type and Dll4-/- embryos was carried out. In wild-type and heterozygous embryos the VEGFR-2 gene was found to be more strongly expressed in the venous endothelium than in the arterial endothelial cells, where the Dll4 gene is strongly expressed (Fig. 5B, C). Interestingly, in the Dll4-/- embryos the expression level of VEGFR-2 in arterial endothelial cells is higher and similar to its expression in veins (Fig. 5D). In situ hybridization for VEGFR-1 and imunostaining for endoglin was carried out without detection of any clear difference between Dll4+/+ and Dll4-/- aortae. Together these results show that, in relation to their wild-type counterparts, Dll4-/- endothelial cells express more VEGFR-2 and Robo4, both of which are involved in the regulation of endothelial cell proliferation and migration [23,26-28] and express less the TGF-beta accessory receptor endoglin, which when ablated in vitro increases endothelial cell proliferation [29] and in vivo decreases arterial stability and smooth muscle cell recruitment [30].
###end p 46
###begin title 47
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
Notch-Dll4 signalling in developing arteries does not occur through lateral inhibition
###end title 47
###begin p 48
Notch signalling, in most cellular processes studied so far, functions through lateral inhibition, where a Notch signal receiving cell upregulates the expression of the Hes/Hey genes and downregulates the expression of Delta. This cell can no longer activate the pathway in neighbouring cells (that will in turn express more Delta) and therefore will acquire a different fate. This mechanism allows the differentiation between initially equivalent cells.
###end p 48
###begin p 49
###xml 123 129 123 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1</italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey1 </italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 508 515 508 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey1 </italic>
###xml 598 603 598 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A, B</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 716 724 716 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 742 749 742 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 864 869 864 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D, E</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 1010 1017 1010 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 1100 1102 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 1207 1211 1207 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1222 1227 1222 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey1 </italic>
###xml 1345 1349 1345 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1349 1353 1349 1353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1362 1369 1362 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 1539 1541 1539 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6G</xref>
###xml 1593 1600 1593 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 1670 1677 1670 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 1740 1745 1740 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 1797 1801 1797 1801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1843 1847 1843 1847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1847 1851 1847 1851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1877 1882 1877 1882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey1 </italic>
###xml 1899 1904 1899 1904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H, I</xref>
###xml 1052 1060 <span type="species:ncbi:405018">cardinal</span>
###xml 1518 1526 <span type="species:ncbi:405018">cardinal</span>
To understand how the Notch pathway regulates endothelial cell differentiation, we analysed endothelial cell expression of Notch1, Dll4 and Hey1 in early development of the arteries (dorsal aortae). In the initial stages of arterial development, Dll4 expression is patchy and not detected in all endothelial cells (data not shown). Some hours later, its expression is present in almost all endothelial cells of the dorsal aortae, although the level of expression differs from cell to cell. The expression of Notch1 and the effector Hey1 is also found in almost all arterial endothelial cells (Fig. 6A, B and 6C), which suggest that these genes can be expressed in the same cells. To explore this possibility, double in situ hybridization for Notch1 and Dll4 mRNA was carried out, showing that these genes are indeed expressed at high levels in the same cell (Fig. 6D, E and 6F). These results indicate that Notch activation in the arterial endothelium by Dll4 is likely to be inductive rather than inhibitory. Notch1 expression is also detected in the cardinal vein endothelium at early stages (Fig. 6D), but here it is lower than in the dorsal aortae, probably due to lack of Notch signalling induction by Dll4. In fact, Hey1 expression was not detected in the venous endothelium even at earlier stages of vein development (data not shown). In Dll4-/- embryos, Notch1 expression was still detected in both veins and dorsal aortae, but in these embryos the expression levels seem to be equal between dorsal aortae and cardinal veins (Fig. 6G), suggesting that there is always a basal level of Notch1 expression that is independent of Dll4, and that Dll4 further induces Notch1 expression levels. Furthermore, there is a basal expression of Dll4 that is independent of Notch1 activation, since the Dll4-lacZ reporter gene is still expressed in Dll4-/- embryos in the absence of Hey1 expression (Fig. 6H, I).
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 289 298 <span type="species:ncbi:7955">zebrafish</span>
###xml 303 308 <span type="species:ncbi:10090">mouse</span>
The initial steps of arterial morphogenesis require the migration of endothelial precursors and their assembly into lumenized vessels. Shortly after these vessels grow and branch accordingly to the cues provided by the surrounding tissues. Previous studies with Notch signalling defective zebrafish and mouse embryos showed the importance of the pathway in early arteriogenesis [11,31]. Here we show that the Notch ligand Dll4 regulates the arterial calibre and lumen by modulating the endothelial cell response to angiogenic factors like VEGF (Fig. 7).
###end p 51
###begin p 52
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Regulation of arterial calibre and endothelial cell migration by Dll4</bold>
###xml 206 211 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 590 594 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 594 598 594 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
Regulation of arterial calibre and endothelial cell migration by Dll4. Model illustrating the difference in the behaviour of endothelial cells in the presence or absence of Notch signalling mediated by the Dll4 ligand in the early embryo arterial endothelium. The loss of Notch signalling leads to downregulation of arterial specific genes and upregulation of VEGFR-2 which may increase migration and proliferation of endothelial cells. The dorsal aortae (da) endothelial cells migrate towards the lateral region of the neural tube (nt) or pre-formed veins (v) with which they fuse. In the Dll4+/+ embryos Notch signalling induces arterial endothelial cell differentiation and stabilization, as well as promoting the formation of a consistent basement membrane (bm).
###end p 52
###begin p 53
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 593 599 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Efnb2 </italic>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 630 634 630 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 634 638 634 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 761 765 761 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 765 769 765 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1142 1147 1142 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 1208 1214 1208 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1</italic>
###xml 1216 1221 1216 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 1225 1230 1225 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hey1 </italic>
###xml 1266 1273 1266 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
The Dll4 gene is strongly expressed in the primordial arteries and heart of early embryos and its complete loss of function causes early and severe vascular defects [15]. As disruption of heart morphogenesis in several mutants is coincident with defects in vascular development, it is sometimes difficult to discern if failure of perfusion led to defective vascular development, or whether the vascular developmental defect is an independent event. Furthermore, in the early embryo it has previously been shown that blood flow can regulate the expression of some arterial specific genes, like Efnb2 [21], which is not detected in Dll4-/- arterial endothelial cells [15]. To clarify if the early phenotype is caused by endothelial or cardiac/blood flow defects, Dll4-/- embryos were analysed before the onset of circulation. The results indicate that the arterial calibre reduction in these mutants is already clear at 8 ss, thus occurs earlier than the establishment of perfusion, and therefore cannot be caused by impaired haemodynamic forces but constitutes a primary vascular defect. This very early remodelling defect suggested a role of Dll4 in early vasculogenesis. However, the expression analysis of Notch1, Dll4 and Hey1 in early embryos revealed that only Notch1 can be expressed in angioblasts, which excludes the involvement of the Dll4 ligand in the initial endothelial cell differentiation from mesodermally derived cells.
###end p 53
###begin p 54
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Jagged1</italic>
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Jag1</italic>
###xml 133 136 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Jag</italic>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Jag1 </italic>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 440 444 440 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Jagged1(Jag1) is another Notch ligand that is also expressed in the early embryo arterial endothelium. Total or endothelial specific Jag1 loss of function leads to embryo death at 10.5 dpc [32,33], one day later than loss of Notch1 or Dll4. Endothelial Jag1 mutants show defects in the development of the arterial vascular smooth muscle without having a decrease of Notch signalling in endothelial cells [32]. Our results show that the Dll4-/- embryos suffer severe arterial calibre reduction before the existence of clearly differentiated smooth muscle cells (alpha-SMA+). Furthermore the mutant aortas are surrounded by neural crest derived smooth muscle cell progenitors (SM22alpha+), some of which are associated with the reduced mutant arterial endothelium. However these results do not exclude a role of Dll4 in arterial smooth muscle development at later stages of development.
###end p 54
###begin p 55
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 101 105 101 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 995 999 995 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 999 1003 999 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1281 1285 1281 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1285 1289 1285 1289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2050 2052 2050 2052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
The morphologic analysis of early (6-10 ss) dorsal aortae shows that the arterial calibre of the Dll4-/- embryos is much smaller than that of the wild-type, even though the number of endothelial cells is only slightly reduced. In addition, there is lack of a uniform laminin-rich basement membrane under the endothelial cells and a defective deposition of endothelial matrix proteins like collagenIV and specially fibronectin. Thus the abnormal organization of the mutant endothelial cells can be partially explained by defects in the formation of a proper endothelial basement membrane. These defects could be the result of either reduced production or active degradation of the basement membrane components. One of the most obvious consequences of this arterial cohesion defect is the extensive haemorrhaging observed in these mutant embryos upon the onset of blood flow. Interestingly, the defect observed in the basement membrane occurs in both the reduced and normal calibre regions of the Dll4-/- dorsal aortae. This suggests that the arterial calibre reduction is not solely caused by a weaker and incomplete, and thus permissive, basement membrane, although this may influence the behaviour of endothelial cells in the presence of adequate angiogenic stimuli. In fact, the Dll4-/- dorsal aortae present a normal calibre only in the presomitic region, where VEGF is produced exclusively by the endoderm. In the anterior and middle somitic regions of the embryo, VEGF is also produced by the neural tube and somites, forming a concentration gradient within the newly formed intersomitic spaces, and this difference in VEGF production may underlie the difference in arterial diameter between the anterior and posterior regions of the embryo. Besides VEGF, other neural tube derived factors like slits, semaphorins and netrins can attract endothelial cells and be responsible for the correct alignment of the dorsal aortae, since ablation of VEGF in the peripheral nerves of the skin does not impair the co-alignment between arteries and nerves [34].
###end p 55
###begin p 56
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 875 884 875 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1026 1034 1026 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 897 902 <span type="species:ncbi:9606">human</span>
The Dll4-/- aortic endothelial cells are likely to respond more than their wild-type counterparts to the neural tube or somite secreted factors, because they migrate earlier and in higher numbers. Alternatively these mutant endothelial cells could be less susceptible to the repulsive factors produced in neural tube or somites. This is unlikely, as vascular invasion of somites or neural tube was not observed. Besides increased migration, the mutant arterial endothelial cells have increased proliferation to nearly twice that of wild-type endothelial cells, which further confirms the higher responsiveness of these cells to local angiogenic factors. These results indicate that the observed smaller arterial calibre and reduced number of endothelial cells is caused by an active outward cell migration that overcomes the increase in arterial cell proliferation. Previous in vitro studies with human endothelial cells also demonstrated that Notch signalling activation decreases endothelial cell proliferation [35,36]. Our in vivo findings are consistent with these observations and suggest that Dll4 induced Notch signalling can be a physiological inhibitor of endothelial cell proliferation, allowing cells to differentiate and form an optimal vascular lumen.
###end p 56
###begin p 57
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 320 328 320 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 598 606 598 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1140 1144 1140 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1145 1150 1145 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 1163 1170 1163 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1 </italic>
###xml 1177 1181 1177 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1181 1185 1181 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 646 651 <span type="species:ncbi:10090">mouse</span>
The role of Notch signalling in early angiogenesis appears therefore to be fundamentally different than that described in Notch regulation of early neurogenesis, in which a pool of non-committed neuroblasts is induced to proliferate and prevented from differentiating by Notch controlled lateral inhibition [37,38]. The in situ hybridization data in the current study suggests that arterial endothelial Notch signalling is inductive rather than inhibitory because the Notch1 receptor and the Dll4 ligand are expressed at high levels in the same cell and almost in all aortic endothelial cells. The in vivo activation of Notch signalling in adult mouse arteries leads to increased expression of the ligand Dll4, Notch receptors, and downstream effectors such as bHLH transcription factor Hey1, which supports the possibility that Notch signalling induces a positive loop in endothelial cells resulting in induction of Notch receptor and its cognate ligand [39]. Furthermore there is a basal level of Notch1 and Dll4 expression in arterial endothelial cells that is independent of Notch-Dll4 signalling, since there is expression of both the Dll4-lacZ reporter and Notch1 in the Dll4-/- mutants.
###end p 57
###begin p 58
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 368 377 368 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 559 563 559 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 720 728 720 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 741 748 741 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo-4 </italic>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 966 970 966 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 970 974 970 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1085 1092 1085 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo-4 </italic>
###xml 1121 1130 1121 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1259 1263 1259 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 1263 1267 1263 1267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1376 1383 1376 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo-4 </italic>
###xml 1405 1410 1405 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 1450 1452 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1478 1485 1478 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo-4 </italic>
###xml 1543 1548 1543 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4 </italic>
###xml 1549 1551 1549 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1575 1582 1575 1582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Robo-4 </italic>
###xml 1657 1659 1657 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1994 1996 1994 1996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 2222 2225 2219 2222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eng</italic>
###xml 2225 2229 2222 2226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2398 2404 2395 2401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Efnb2 </italic>
###xml 2416 2418 2413 2415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 2419 2421 2416 2418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 2437 2446 2434 2443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 2464 2467 2461 2464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eng</italic>
###xml 2467 2471 2464 2468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2519 2521 2516 2518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 751 760 <span type="species:ncbi:7955">zebrafish</span>
###xml 974 979 <span type="species:ncbi:10090">mouse</span>
###xml 1465 1470 <span type="species:ncbi:10090">mouse</span>
###xml 1589 1594 <span type="species:ncbi:10090">mouse</span>
The RT-PCR and in situ hybridization results obtained are consistent with the observed mutant endothelial cell behaviour. The Dll4-/- arterial endothelial cells express more VEGFR-2 which is required for VEGF mediated endothelial cell migration and proliferation [40]. This direct relationship between VEGF signalling and the Notch pathway was previously suggested by in vitro studies with HUVECs where Notch activation, through the upregulation of Dll4, reduces the expression of VEGFR-2 and Nrp-1 [41,42]. The receptor Robo-4 is also upregulated in the Dll4-/- embryos. At the stages analysed it is expressed throughout the endothelial network and, like VEGFR-2, it is further induced at sites of active angiogenesis. In vivo knockdown of Robo-4 in zebrafish embryos suppresses the formation of intersomitic vessels due to inhibition of endothelial cell sprouting and migration, seen by time-lapse analysis [23], which is the opposite to the phenotype observed in Dll4-/- mouse embryos. Robo-4 also participates in attraction-guidance through Rho-GTPases in vascular development, as Robo-4 gain of function experiments in vitro showed activation of Cdc42 and Rac1 Rho-GTPases [26]. Therefore Robo-4 may be one of the mediators of the increased migration of Dll4-/- endothelial cells in response to its ligand Slit produced by the somites and the neural tube. Interestingly, Robo-4 levels decline in the Dll4 expressing dorsal aortae after 9.0 dpc [24] and in the mouse retina Robo-4 is not expressed in the tip cells known to highly express Dll4 [28]. However, deletion of Robo-4 in the mouse is not lethal and developmental angiogenesis occurs normally [28], suggesting that its function might be compensated by other genes. Nonetheless its loss of function enhances post-natal induced pathologic angiogenesis and endothelial permeability. This inhibition is thought to depend on Slit2-Robo4 suppression of VEGF165-Src induced endothelial migration and tube formation but not proliferation [28]. Although controversial these results suggest that Robo4 could act differently during development and pathological angiogenesis. We also found a significant reduction in the expression of the TGF-beta1 co-receptor endoglin. Eng-/- mutant embryos die around 10.5 dpc due to several cardiovascular defects that also include abnormal arterio-venous fusions, and this phenotype is independent of loss of Efnb2 expression [30,43]. Furthermore, in vitro studies show that Eng-/- endothelial cells have increased proliferation [29].
###end p 58
###begin p 59
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
The vessel response to angiogenic factors must be tightly regulated to ensure a balance between the formation of new sprouts and the remodelling of previously formed vessels. Such regulation allows the formation of a hierarchical system of vessels with critical contribution from the Notch-Dll4 pathway, which modulates VEGF signalling in endothelial cells. An important example of this role has been recently reported in relation to the vascularisation of the retina in newborn mice [44-46].
###end p 59
###begin p 60
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 29 33 29 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll4</italic>
###xml 218 222 218 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 90 98 <span type="species:ncbi:405018">cardinal</span>
We observed migration of Dll4-/- aortic endothelial cells towards the developing anterior cardinal veins in the dorso-lateral region of the neural tube (Fig. 7). This migration and delocalization of the "arterial" Dll4-/- endothelial cells to the assembly region of the primordial veins may be related to faulty differentiation [13,15,31,47] and increased responsiveness to the angiogenic factors.
###end p 60
###begin p 61
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
VEGF induces expression of Dll4 [48] which in turn, by activating the Notch pathway, reduces endothelial cell sensitivity and responsiveness to VEGF. We thus suggest that the Notch pathway could constitute a negative feedback mechanism to ensure that the formation and extension of new arterial vessel branches occurs only after the growth and stabilization of the preceding main arterial vessels. Without Notch signalling the arterial endothelial cells proliferate and migrate in an uncontrolled manner, resulting in the formation of a vasculature that is not efficient in blood distribution due to exaggerated branching and extension of the preformed vessels. A number of recent reports indicate that this is also the case during tumour neoangiogenesis, with loss of Notch activation by Dll4 resulting in an inefficient vascular bed due to a disproportionate increase in vessel branching [49-51].
###end p 61
###begin title 62
Conclusion
###end title 62
###begin p 63
###xml 117 122 <span type="species:ncbi:10090">mouse</span>
Many of the currently used anti- or pro-angiogenic therapies were designed after important findings concerning early mouse embryo vascular development. The present data shows that activation of the Notch pathway by the ligand Dll4 can regulate several different key steps in arteriogenesis through interaction with other important endothelial signalling mechanisms. The understanding of these interactions between different signalling pathways offers alternatives for future therapeutic intervention.
###end p 63
###begin title 64
Authors' contributions
###end title 64
###begin p 65
RB participated in the design of the studies, acquisition of the data, preparation of the figures and writing of the manuscript. AT participated in the experiments discussion, improved some techniques and revised the manuscript. MH carried out the first experiments which originated this research work and revised the manuscript. DH, LLC, JR and PSG participated in the discussion of the experiments and revision of the manuscript. AD conceived the study, participated in its design and coordination and helped write the manuscript. All authors read and approved the final manuscript.
###end p 65
###begin title 66
Acknowledgements
###end title 66
###begin p 67
We thank Dr. Susana Rocha for helpful discussions and technical advice and Eng. Patricia Diniz for expert technical assistance. DH is supported by the Portuguese Science and Technology Foundation (FCT; grant POCTI/BCI/4883). JR is supported by a grant from the National Cancer Institute of Canada with funds from the Terry Fox Foundation. PSG is supported by the National Cancer Institute (USA). AD is supported by FCT (grants POCTI/CVT/48766 and POCTI/CVT/56015). RB and AT are recipients of a PhD studentship from FCT.
###end p 67
###begin article-title 68
Mechanisms of angiogenesis
###end article-title 68
###begin article-title 69
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
###end article-title 69
###begin article-title 70
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
###end article-title 70
###begin article-title 71
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
###end article-title 71
###begin article-title 72
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
###end article-title 72
###begin article-title 73
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
###end article-title 73
###begin article-title 74
Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
###end article-title 74
###begin article-title 75
The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis
###end article-title 75
###begin article-title 76
Guidance of vascular and neural network formation
###end article-title 76
###begin article-title 77
Signaling pathways in vascular development
###end article-title 77
###begin article-title 78
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Notch signaling is essential for vascular morphogenesis in mice
###end article-title 78
###begin article-title 79
Dll4, a novel Notch ligand expressed in arterial endothelium
###end article-title 79
###begin article-title 80
Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants
###end article-title 80
###begin article-title 81
Haploinsufficiency of delta-like 4 ligand results inembryonic lethality due to major defects in arterial and vascular development
###end article-title 81
###begin article-title 82
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
Dosage-sensitive requirement for mouse Dll4 in artery development
###end article-title 82
###begin article-title 83
flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors
###end article-title 83
###begin article-title 84
HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments
###end article-title 84
###begin article-title 85
Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
###end article-title 85
###begin article-title 86
###xml 2 7 <span type="species:ncbi:9031">chick</span>
A chick homologue of Serrate and its relationship with Notch and Delta homologues during central neurogenesis
###end article-title 86
###begin article-title 87
###xml 54 59 <span type="species:ncbi:9031">chick</span>
Flow regulates arterial-venous differentiation in the chick embryo yolk sac
###end article-title 87
###begin article-title 88
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Vasculogenesis in the day 6.5 to 9.5 mouse embryo
###end article-title 88
###begin article-title 89
roundabout4 is essential for angiogenesis in vivo
###end article-title 89
###begin article-title 90
Robo4 is a vascular-specific receptor that inhibits endothelial migration
###end article-title 90
###begin article-title 91
Endoglin expression in early development is associated with vasculogenesis and angiogenesis
###end article-title 91
###begin article-title 92
Robo4 signaling in endothelial cells implies attraction guidance mechanisms
###end article-title 92
###begin article-title 93
The biology of VEGF and its receptors
###end article-title 93
###begin article-title 94
Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability
###end article-title 94
###begin article-title 95
Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway
###end article-title 95
###begin article-title 96
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Defective angiogenesis in mice lacking endoglin
###end article-title 96
###begin article-title 97
Notch signaling is required for arterial-venous differentiation during embryonic vascular development
###end article-title 97
###begin article-title 98
Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development
###end article-title 98
###begin article-title 99
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1
###end article-title 99
###begin article-title 100
Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback
###end article-title 100
###begin article-title 101
Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis
###end article-title 101
###begin article-title 102
Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1
###end article-title 102
###begin article-title 103
Neurogenic genes and vertebrate neurogenesis
###end article-title 103
###begin article-title 104
###xml 91 96 <span type="species:ncbi:9031">chick</span>
Maintenance of neuroepithelial progenitor cells by Delta-Notch signalling in the embryonic chick retina
###end article-title 104
###begin article-title 105
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice
###end article-title 105
###begin article-title 106
Angiogenesis as a therapeutic target
###end article-title 106
###begin article-title 107
Upregulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function
###end article-title 107
###begin article-title 108
Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression
###end article-title 108
###begin article-title 109
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development
###end article-title 109
###begin article-title 110
The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching
###end article-title 110
###begin article-title 111
Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting
###end article-title 111
###begin article-title 112
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
###end article-title 112
###begin article-title 113
sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation
###end article-title 113
###begin article-title 114
Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis
###end article-title 114
###begin article-title 115
Inhibition of Dll4 mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion
###end article-title 115
###begin article-title 116
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
###end article-title 116
###begin article-title 117
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
###end article-title 117

